These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16603535)

  • 21. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active.
    Kotler M; Arad G; Hughes SH
    J Virol; 1992 Nov; 66(11):6781-3. PubMed ID: 1404618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and enzymatic characterization of XMRV protease by a cell-free proteolytic analysis.
    Matsunaga S; Sawasaki T; Ode H; Morishita R; Furukawa A; Sakuma R; Sugiura W; Sato H; Katahira M; Takaori-Kondo A; Yamamoto N; Ryo A
    J Proteomics; 2012 Aug; 75(15):4863-73. PubMed ID: 22687250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
    Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
    Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein.
    Paulus C; Hellebrand S; Tessmer U; Wolf H; Kräusslich HG; Wagner R
    J Biol Chem; 1999 Jul; 274(31):21539-43. PubMed ID: 10419458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
    Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
    J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point mutation in avian sarcoma leukaemia virus protease which increases its activity but impairs infectious virus production.
    Arad G; Chorev M; Shtorch A; Goldblum A; Kotler M
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1917-25. PubMed ID: 7543558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
    Menéndez-Arias L; Gotte D; Oroszlan S
    Virology; 1993 Oct; 196(2):557-63. PubMed ID: 8372434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
    Song YE; Olinger GY; Janaka SK; Johnson MC
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants.
    Pazhanisamy S; Stuver CM; Cullinan AB; Margolin N; Rao BG; Livingston DJ
    J Biol Chem; 1996 Jul; 271(30):17979-85. PubMed ID: 8663409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
    Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
    Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli.
    Fehér A; Boross P; Sperka T; Oroszlan S; Tözsér J
    Protein Expr Purif; 2004 May; 35(1):62-8. PubMed ID: 15039067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants.
    Chen YL; Ts'ai PW; Yang CC; Wang CT
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2497-501. PubMed ID: 9349470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases.
    Menéndez-Arias L; Weber IT; Oroszlan S
    J Biol Chem; 1995 Dec; 270(49):29162-8. PubMed ID: 7493942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
    Wu X; Liu H; Xiao H; Conway JA; Kappes JC
    J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
    Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
    Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors.
    Jinnopat P; Isarangkura-na-ayuthaya P; Utachee P; Kitagawa Y; de Silva UC; Siripanyaphinyo U; Kameoka Y; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):320-8. PubMed ID: 19727001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
    Zhao W; Akkawi C; Mougel M; Ross SR
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
    Bowzard JB; Bennett RP; Krishna NK; Ernst SM; Rein A; Wills JW
    J Virol; 1998 Nov; 72(11):9034-44. PubMed ID: 9765448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.
    el-Farrash MA; Kuroda MJ; Kitazaki T; Masuda T; Kato K; Hatanaka M; Harada S
    J Virol; 1994 Jan; 68(1):233-9. PubMed ID: 8254733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.